Spironolactone use and risk of incident cancers: a retrospective, matched cohort study

Aims Spironolactone is widely used to treat heart failure, hypertension and liver disease with increased usage in recent years. Spironolactone has endocrine effects that could influence cancer risks and historical reports suggest possible links with increased risk of certain types of cancer. The aim...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of clinical pharmacology Jg. 83; H. 3; S. 653 - 663
Hauptverfasser:	Mackenzie, Isla S., Morant, Steven V., Wei, Li, Thompson, Alastair M., MacDonald, Thomas M.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	England John Wiley and Sons Inc 01.03.2017
Schlagworte:	Adult Aged Aged, 80 and over cancer Case-Control Studies cohort study Female Humans Incidence Male Middle Aged Neoplasms - chemically induced Neoplasms - epidemiology Pharmacoepidemiology Proportional Hazards Models prostate Retrospective Studies Risk Factors spironolactone Spironolactone - adverse effects United Kingdom - epidemiology Young Adult cancer prostate cohort study spironolactone pharmacoepidemiology
ISSN:	0306-5251, 1365-2125, 1365-2125
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!